Jump Financial, LLC Grifols Sa Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Oct 21, 2024	BUY	$7.71 - $11.56 $245,879 - $368,659	31,891 Added 214.96%	46,727 $540,000
Q4 2023 Feb 07, 2024	BUY	$7.71 - $11.56 $245,879 - $368,659	31,891 Added 214.96%	46,727 $540,000
Q3 2023 Oct 21, 2024	SELL	$8.91 - $10.91 $499,851 - $612,051	-56,100 Reduced 79.09%	14,836 $135,000
Q3 2023 Nov 07, 2023	BUY	$8.91 - $10.91 $132,188 - $161,860	14,836 New	14,836 $135,000
Q1 2023 Oct 21, 2024	BUY	$6.65 - $10.69 $471,724 - $758,305	70,936 New	70,936 $522,000
Q1 2023 May 03, 2023	BUY	$6.65 - $10.69 $471,724 - $758,305	70,936 New	70,936 $522,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.